These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36018830)

  • 21. Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
    Li JJ; Hu Y; Hu B; Wang W; Xu H; Hu XY; Ding F; Li HB; Wang KR; Zhang X; Guo DS
    Nat Commun; 2022 Oct; 13(1):6279. PubMed ID: 36270992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
    Oo TZ; Cole N; Garthwaite L; Willcox MD; Zhu H
    J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
    Lewis GJ; Fang X; Gooch M; Cook PP
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
    Srivastava P; Sivashanmugam K
    Infect Genet Evol; 2021 Aug; 92():104824. PubMed ID: 33774177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F; Bahamondez-Canas TF; Moraga-Espinoza D; Smyth HDC; Watts AB
    Eur J Pharm Biopharm; 2020 Jul; 152():210-217. PubMed ID: 32442738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.
    Buyck JM; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2015 Jan; 59(1):258-68. PubMed ID: 25348528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
    Hazlett LD; Ekanayaka SA; McClellan SA; Francis R
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2978-2989. PubMed ID: 31311033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa.
    Kim H; Jang JH; Kim SC; Cho JH
    Eur J Med Chem; 2020 Jan; 185():111814. PubMed ID: 31678742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antibacterial activities of cyanidinum chloride-loaded liposomes against a resistant strain of Pseudomonas aeruginosa.
    Gharib A; Faezizadeh Z; Mesbah-Namin SA
    Planta Med; 2013 Jan; 79(1):15-9. PubMed ID: 23203413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chinese expert consensus on the management of lower respiratory tract infections of
    Pulmonary Infection Assembly of Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa.
    Pushparaj Selvadoss P; Nellore J; Balaraman Ravindrran M; Sekar U; Tippabathani J
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):268-273. PubMed ID: 28362119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
    Chaudhry NA; Tabandeh H; Rosenfeld PJ; Miller D; Davis J
    Arch Ophthalmol; 1998 Sep; 116(9):1251. PubMed ID: 9747696
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
    Hyatt JM; Schentag JJ
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Willcox MD
    Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.
    Millar BC; McCaughan J; Rendall JC; Moore JE
    Clin Respir J; 2021 Jan; 15(1):116-120. PubMed ID: 32790958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.